BDXB Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2023 @ 16:00):

Stats
Today's Volume	2.76M
Average Volume	449 584
Market Cap	13.69B
EPS	$0.526 ( 2023-09-29 )
Last Dividend	$0.750 ( 2023-02-14 )
Next Dividend	$0 ( N/A )
P/E	7.60
ATR14	$0.267 (0.55%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-16	Goette Roland	Sell	2 233	Common Stock
2024-01-03	Shan David	Sell	44	Common Stock
2017-12-29	Ring Timothy M	Sell	0	Common Stock
2023-01-24	Jones Christopher Ian Montague	Buy	848	Common Stock
2023-12-11	Garrison Michael David	Sell	1 239	Common Stock

INSIDER POWER
62.44
Last 100 transactions
Buy: 250 011 \| Sell: 82 118

Volume Correlation

Long: -0.15 (neutral)

Short: -0.69 (moderate negative)

Signal:(30.604) Neutral

Becton, Dickinson and Correlation

10 Most Positive Correlations
AGQ	0.869
SLV	0.857
SIVR	0.856
PSLV	0.853
SO	0.821
TDI	0.817
AEM	0.805

10 Most Negative Correlations
ZSL	-0.852
NM	-0.84
INSW	-0.831
TEX	-0.821
ASC	-0.818
TNP	-0.817
STAR	-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Becton, Dickinson and Correlation - Currency/Commodity

-0.04
( neutral )

-0.13
( neutral )

-0.45
( neutral )

-0.33
( neutral )

0.24
( neutral )

-0.19
( neutral )

Becton, Dickinson and Financials

Annual	2023
Revenue:	$19.37B
Gross Profit:	$8.17B (42.17 %)
EPS:	$4.97

Q4	2023
Revenue:	$5.09B
Gross Profit:	$1.70B (33.44 %)
EPS:	$0.370

Q3	2023
Revenue:	$4.88B
Gross Profit:	$2.10B (43.05 %)
EPS:	$1.370

Q2	2023
Revenue:	$4.82B
Gross Profit:	$2.24B (46.36 %)
EPS:	$1.540

Financial Reports:

No articles found.

Becton, Dickinson and Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.750 (N/A)	$0.750 (N/A)	$0.750 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Becton, Dickinson and Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.43 - good (94.26%) | Divividend Growth Potential Score: 4.08 - Stable (18.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.792	2020-08-13
Last Dividend	$0.750	2023-02-14
Next Dividend	$0	N/A
Payout Date	2023-03-01
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$8.29	--
Avg. Dividend % Per Year	2.49%	--
Score	4.63	--
Div. Sustainability Score	9.43
Div.Growth Potential Score	4.08
Div. Directional Score	6.75	--

Next Divdend (Est)
(2024-07-01)

$0.763 Estimate 2.12 %

Dividend Stability

0.17 Bad

Dividend Score

4.63

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2020	$1.542	3.58%
2021	$3.00	5.44%
2022	$3.00	5.65%
2023	$0.750	1.49%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend Royal	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Royal	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0644	1.500	8.71	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0240	1.200	9.20	10.00	[0 - 0.3]
returnOnEquityTTM	0.0489	1.500	-0.568	-0.852	[0.1 - 1]
payoutRatioTTM	0.882	-1.000	1.178	-1.178	[0 - 1]
currentRatioTTM	1.082	0.800	9.59	7.67	[1 - 3]
quickRatioTTM	0.457	0.800	-2.02	-1.612	[0.8 - 2.5]
cashRatioTTM	0.156	1.500	-0.242	-0.363	[0.2 - 2]
debtRatioTTM	0.308	-1.500	4.86	-7.30	[0 - 0.6]
interestCoverageTTM	8.19	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	11.82	2.00	6.06	10.00	[0 - 30]
freeCashFlowPerShareTTM	9.13	2.00	5.44	10.00	[0 - 20]
debtEquityRatioTTM	0.636	-1.500	7.46	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.414	1.000	6.44	6.44	[0.2 - 0.8]
operatingProfitMarginTTM	0.101	1.000	9.98	9.98	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.213	1.000	9.93	9.93	[0.2 - 2]
assetTurnoverTTM	0.373	0.800	-0.847	-0.678	[0.5 - 2]
Total Score				9.43

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	55.66	1.000	4.48	0	[1 - 100]
returnOnEquityTTM	0.0489	2.50	-0.365	-0.852	[0.1 - 1.5]
freeCashFlowPerShareTTM	9.13	2.00	6.96	10.00	[0 - 30]
dividendYielPercentageTTM	1.544	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	11.82	2.00	6.06	10.00	[0 - 30]
payoutRatioTTM	0.882	1.500	1.178	-1.178	[0 - 1]
pegRatioTTM	0.238	1.500	-1.749	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.176	1.000	8.10	0	[0.1 - 0.5]
Total Score				4.08

Becton, Dickinson and

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.